Table IV.
Group | IL-1 (pg/ml) | IL-2 (pg/ml) | TNF-α (pg/ml) | IFN-γ (pg/ml) | IL-10 (pg/ml) |
---|---|---|---|---|---|
Normal control | 43.36±12.32 | 59.33±21.32 | 49.55±19.34 | 39.44±15.21 | 54.22±24.54 |
AD control | 143.21±34.21 | 121.32±12.43 | 109.22±22.12 | 108.23±35.21 | 41.21±19.32 |
Stem cell treatment | 53.21±19.43a | 67.35±21.11a | 55.21±20.32a | 44.43±19.54a | 47.43±17.43 |
P<0.05, compared with the AD control group. AD, Alzheimer's disease; IL, interleukin; TNF-α, tumor necrosis factor-α; IFN-γ, interferon-γ.